avelumab,Atezolizumab
merck,Pfizer,roche
['biomarker', 'marker ']
wonderful discussion from , with a masterful breakdown of the strengths and limitations of these biomarker studies #esmo22 
Oncologist, physician-scientist, Assistant Professor @YaleCancer @YaleMed | cancer immunotherapy, genomics, kidney cancer | tweets ? medical advice.